CLCSOTCPharmaceutical PreparationsFiscal year ends December 31
Cell Source, Inc.
Financials through Q1 FY2025, quarter ended Mar 31, 2025Last filing: 10-Q on May 14, 2026
$0.49−0.00 (-0.01%)
Close on Oct 19, 2026
- Market cap
- $21.99M
- P/E (TTM)
- –
- Dividend yield
- –
Cell Source, Inc. cash flow statement
Ratios
Latest available, balances at Mar 31, 2025
Profitability, FY
- Gross margin
- –
- Operating margin
- –
- Net margin
- –
- Return on equity, FY2024
- 26.4%
Financial strength
- Current ratio
- –
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- –
Valuation
- P/E ratio
- –
- Price to sales
- –
- Price to book
- –
- Dividend yield
- –